Colchicine: an emerging treatment for coronary artery disease
Coronary artery disease (CAD) is one of the leading causes of death worldwide. These rates are only likely to be buoyed in the future by the rising prevalence of obesity, diabetes, and metabolic syndrome. The pathogenesis of atherosclerosis, the main cause of CAD, has been a topic of great interest....
Main Authors: | Waseem Hijazia, Sanjit S. Jolly |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2021-08-01
|
Series: | REC: Interventional Cardiology (English Ed.) |
Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=630 |
Similar Items
-
Colchicina: una terapia emergente para el tratamiento de la enfermedad coronaria
by: Waseem Hijazia, et al.
Published: (2021-08-01) -
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Thomas Kofler, et al.
Published: (2021-08-01) -
Colchicine for Coronary Artery Disease: A Review
by: Tao Chen, et al.
Published: (2022-06-01) -
Colchicine as an Adjuvant Therapy for Coronary Artery Disease: A Systematic Review
by: Nobian Andre, et al.
Published: (2020-11-01) -
Inflammatory hypothesis of atherogenesis: Will colchicine be added to the armamentarium in the prevention of coronary artery disease?
by: Bahadir Simsek, et al.
Published: (2021-09-01)